comparemela.com

Latest Breaking News On - இறப்பு இறக்கும் - Page 12 : comparemela.com

Classic triad of symptoms misses positive COVID-19 cases, study finds

University of Limerick research finds new link between personality and risk of death

 E-Mail Ground-breaking research led by University of Limerick has revealed for the first time that the immune system directly links personality to long-term risk of death. The study sheds new light on why people who are more conscientious tend to live longer. Results from the new international study published in the journal Brain, Behavior, and Immunity have found that the immune system plays a previously unknown role in the link between personality traits and long-term risk of death. Personality is known to be associated with long-term risk of death, it is a well replicated finding observed across numerous research studies internationally, explained Principal Investigator on the study Dr Páraic Ó Súilleabháin, from the Department of Psychology and Health Research Institute at University of Limerick, Ireland.

Treating vision loss globally would see social and economic benefits

 E-Mail An estimated 1.1 billion people were living with untreated vision impairment in 2020, but researchers say more than 90 per cent of vision loss could be prevented or treated with existing, highly cost-effective interventions. Published today in The Lancet Global Health, a new commission report on global eye health calls for eye care to be included in mainstream health services and development policies. It argues that this is essential to achieve the WHO goal of Universal Health Coverage (UHC) and the 2030 United Nations Sustainable Development Goals (SDGs). Written by 73 leading experts from 25 countries, including University of Melbourne Professor Hugh Taylor, the Lancet Global Health Commission Report on Global Eye Health reveals that with the right tools, strategies, and sufficient funding, improving eye health can have immediate and substantial benefits for the economic and social prosperity of individuals and nations.

George Mason, Rutgers partner to better inform HER2 breast cancer treatment

 E-Mail IMAGE: Lance Liotta, MD, PhD, study PI, and George Mason University College of Science CAPMM co-founder and co-director. view more  Credit: Evan Cantwell, George Mason University A George Mason University and Rutgers Cancer Institute of New Jersey collaboration received the U.S. Army s Breast Cancer Research Program (BCRP) Breakthrough Award to quickly confirm if an identified HER2 biomarker can indicate success likelihood of personalized breast cancer treatments. George Mason University s College of Science announced an exciting $1.33 million collaboration with Rutgers Cancer Institute of New Jersey and Mason s Center for Applied Proteomics and Molecular Medicine (CAPMM) which taps cancer research diagnostics and treatment strengths within the medical facilities and CAP/CLIA laboratory respectively of the two regional powerhouses.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.